Mergers and Acquisitions TRANSACTIONAL

WilmerHale lawyers have decades of experience advising public and private companies in all aspects of mergers and acquisitions in both the United States and Europe.


Market leaders in life sciences, technology, financial services, communications and many other industries turn to WilmerHale for legal advice and business advantage. In 2016, we advised clients on more than 75 M&A transactions with an aggregate value of approximately $50 billion, providing guidance in areas including corporate, securities, antitrust and tax. Since 2006, we have participated in more than 1,000 mergers and acquisitions with a total value in excess of $400 billion, ranging from sales of VC-backed companies to multibillion-dollar global mergers. Our experience ranges from public-public M&A transactions and the related disclosure and fiduciary duty issues to the unique issues presented by acquisitions of financial sponsor-backed private companies. We also advise clients on hostile transactions and activist investors, and represent investment banks serving as financial advisors in M&A transactions. 

Contacts

Sort By
Bothwick, Jay E.

Jay E. Bothwick

Co-Chair, Mergers and Acquisitions Practice Group

+1 617 526 6526 (t)

jay.bothwick@wilmerhale.com

Leibowitz, Hal J.

Hal J. Leibowitz

Co-Chair, Mergers and Acquisitions Practice Group

+1 617 526 6461 (t)

hal.leibowitz@wilmerhale.com

Bain, Mick

Mick Bain

Partner

+1 617 526 6158 (t)

michael.bain@wilmerhale.com

Bonnes, Andrew

Andrew Bonnes

Partner

+1 617 526 6136 (t)

andrew.bonnes@wilmerhale.com

Boot, Jeannette K.

Jeannette K. Boot

Partner

+1 212 295 6507 (t)

jeannette.boot@wilmerhale.com

Borden, Mark G.

Mark G. Borden

Partner

+1 617 526 6675 (t)

mark.borden@wilmerhale.com

Bothwick, Jay E.

Jay E. Bothwick

Partner

+1 617 526 6526 (t)

jay.bothwick@wilmerhale.com

Braun, Martin

Dr. Martin Braun

Partner

+49 69 27 10 78 207 (t)

martin.braun@wilmerhale.com

Brown, Lillian

Lillian Brown

Partner

+1 202 663 6743 (t)

lillian.brown@wilmerhale.com

Buckland, Peter

Peter Buckland

Partner

+1 650 858 6036 (t)

peter.buckland@wilmerhale.com

Experience

Representative experience includes:

  • Akamai Technologies' acquisitions of Prolexic Technologies for $403 million and Codemate for $107.5 million;
  • Analog Devices' acquisition of Hittite Microwave for $2.5 billion;
  • Booz Allen Hamilton's acquisition of the Defense Systems Engineering & Support division of ARINC for $154 million;
  • DirectEdge's acquisition by BATS Global Markets (undisclosed purchase price);
  • Durata Therapeutics' acquisition by Actavis for $760 million;
  • Gilt Groupe Holdings' acquisition by Hudson's Bay Company for $250 million;
  • LoopPay's acquisition by Samsung (undisclosed);
  • Palomar Medical Technologies' acquisition by Cynosure for $294 million;
  • Progress Software's acquisition of Telerik for $262.5 million;
  • Sanbolic's acquisition by Citrix Systems for $89.6 million;
  • The Medicines Company's acquisition of Rempex Pharmaceuticals for $474 million (including milestone payments), and in the sale of global portfolio of hemostasis products to Mallinckrodt for $410 million;
  • Thermo Fisher Scientific's sale of its cell culture, gene modulation and magnetic beads businesses to GE Healthcare for $1.06 billion;
  • TEI Biosciences' acquisition by Integra Life Sciences for $312 million; and
  • WEX's acquisition of Electronic Funds Source for $1.4 billion.

Additional M&A experience: 20172016, 20152014, 20132012, 2011, 2010, 2009

Publications & News

View

April 4, 2017

Progress Buys DataRPM for $30M to Build Business Apps

Progress Software, the leading provider of application development and deployment technologies, announced it has completed a $30 million acquisition of DataRPM, a privately held company and leader in cognitive predictive maintenance for the industrial IoT market.

April 3, 2017

WilmerHale Reps Vtesse Inc. in Acquisition by Sucampo

Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, and Vtesse Inc., a privately-held rare disease company, today announced that Sucampo has acquired Vtesse for upfront consideration of $200 million.

March 21, 2017

WilmerHale Recognized for Outstanding International Lawyers and Practices in Chambers Global 2017

Chambers Global has named 27 WilmerHale lawyers among "The World's Leading Lawyers for Business" in its 2017 edition.

March 1, 2017

Selected 2017 M&A Transactions

In 2016, we advised clients on more than 75 M&A transactions with an aggregate value of approximately $50 billion, providing guidance in areas including corporate, securities, antitrust and tax. Since 2006, we have participated in more than 1,000 mergers and acquisitions with a total value in excess of $400 billion, ranging from sales of VC-backed companies to multibillion-dollar global mergers.

February 24, 2017

Amygdala Neurosciences Acquires GS-6637 From Gilead Sciences

On February 16, Amygdala Neurosciences Inc., a biopharmaceutical company focused on the development and commercialization of first-in-class drug candidates for addiction disorders, announced that it entered into an agreement with Gilead Sciences, Inc.

February 15, 2017

WilmerHale Counsels Dextro in Acquisition by TASER

Dextro, Inc., the first computer-vision and deep learning system to make the visual contents in video searchable in real time, has been acquired by TASER International, the global leader in public safety technology.

February 14, 2017

WilmerHale Counsels Cynosure in $1.65B Acquisition by Hologic

The WilmerHale team on the transaction was led by Hal Leibowitz and Jason Kropp and included Andrew Bonnes, Kim Wethly, Leon Greenfield, Bruce Manheim, Steve Barrett, Laura Schneider, Amy Null, Julie Hogan Rodgers, Ciara Baker, Davis Sluis, Caroline Dotolo and Alex Civetta.

February 3, 2017

Park Square and WilmerHale Release 17th Annual Technology and Life Sciences Compensation and Entrepreneurship Study

Growth rate in salaries for private company technology executives track higher than comparable life science leaders for the second year in a row.

February 2, 2017

PAREXEL Announces Definitive Agreement to Acquire The Medical Affairs Company

WilmerHale is serving as legal counsel for PAREXEL in this transaction, with Jeff Hermanson leading the team that includes Julie Fogarty, Scott Kilgore and Julie Hogan Rodgers.

January 21, 2017

Basic HSR Threshold to Increase to $80.8 Million

The Federal Trade Commission announced revised thresholds for merger notifications under the Hart-Scott-Rodino Act. Once effective, the lowest size-of-transaction filing threshold will increase from the current $78.2 million to $80.8 million.